Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on February 11, 2014, to report its financial and operating results for the fourth quarter and full year ended December 31, 2013. The press release containing these results is furnished as an exhibit to this filing, providing investors with key financial data and operational updates for the period. While the 8-K itself is brief, it serves as the official notification and access point for the detailed financial performance announced by the company.
Key Highlights
- 1REGN filed an 8-K on February 11, 2014, announcing Q4 and Full Year 2013 financial and operating results.
- 2The press release containing the detailed results is incorporated by reference as Exhibit 99.1.
- 3This filing serves as the official public disclosure of the company's year-end financial performance.
- 4Investors can access the Q4 and FY 2013 results through the furnished press release.
- 5The filing is primarily an informational event, providing access to previously announced financial data.